Sequel currently conducts collaborative research and development with six separate laboratories in the following institutions: Intrinsic Bioprobes, Inc. of Tempe, Arizona; Neo Gen Screening, Bridgeville, Pennsylvania; Carnegie Mellon University; and the University of Pittsburgh